Snowball logo
logo
0094

Hanall Biopharma

009420 β€’ KO
β‚©60,400.00β‚©0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
101,594.4109,995.4134,909.8138,943.7155,184.5159,064.7
COGS
41,261.848,024.159,737.665,637.374,326.676,092.5
Gross Profit
60,332.661,971.375,172.373,306.480,857.982,972.2
Operating Expenses & Income
Operating Income
10,099.11,505.82,211.4230.5(915.8)317.4
Total Operating Expenses
91,495.3108,489.6132,698.5138,713.2156,100.3158,747.3
R&D Expenses
10,462.416,498.523,94519,992.619,314.917,768.9
Selling General & Admin Expenses
20,523.423,235.925,688.429,951.938,27140,767.8
Earnings from Continuing Operations
Interest Expense
(25.48)(21.88)(63.86)(70.97)(142.5)(494.6)
Interest Income
719.81,426.91,227.4490.3263.1329.8
Income Tax Expense
(194)1,678----
Net Income
Net Income
8,896.1251.53,508.6(1,804.8)(5,559.2)(5,076.6)
Supplemental
EBIT
10,099.11,505.8----
EBITDA
11,452.45,004----
In millions of KRW, except % and values per 1 share